{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:01:42Z","timestamp":1790517702253,"version":"4.1.0"},"reference-count":40,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2017,9,16]],"date-time":"2017-09-16T00:00:00Z","timestamp":1505520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:styled-content style=\"fixed-case\">BK<\/jats:styled-content>\n                      polyomavirus (\n                      <jats:styled-content style=\"fixed-case\">BKP<\/jats:styled-content>\n                      yV) reactivation is a common clinical occurrence in kidney transplant recipients (\n                      <jats:styled-content style=\"fixed-case\">KTR<\/jats:styled-content>\n                      ). Several other polyomaviruses have been implicated as pathogens with a direct role in the development of malignancies, raising the question of whether\n                      <jats:styled-content style=\"fixed-case\">BKP<\/jats:styled-content>\n                      yV might also be oncogenic.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This study is the first retrospective, multicenter cohort study evaluating the relative risk for urothelial cell carcinoma (\n                      <jats:styled-content style=\"fixed-case\">UCC<\/jats:styled-content>\n                      ) associated with\n                      <jats:styled-content style=\"fixed-case\">BKP<\/jats:styled-content>\n                      yV infection among\n                      <jats:styled-content style=\"fixed-case\">KTR<\/jats:styled-content>\n                      , and was conducted among veterans who underwent transplantation between 2000 and 2009.\n                      <jats:styled-content style=\"fixed-case\">BKP<\/jats:styled-content>\n                      yV cases were defined as those veterans with any clinical evidence of\n                      <jats:styled-content style=\"fixed-case\">BKP<\/jats:styled-content>\n                      yV infection, including positive polymerase chain reaction testing of urine and\/or serum for\n                      <jats:styled-content style=\"fixed-case\">BKP<\/jats:styled-content>\n                      yV or kidney biopsy showing\n                      <jats:styled-content style=\"fixed-case\">BKP<\/jats:styled-content>\n                      yV\u2010associated nephropathy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 646 veterans who met inclusion criteria for the study, 103 had clinical evidence of\n                      <jats:styled-content style=\"fixed-case\">BKP<\/jats:styled-content>\n                      yV infection (16%). The overall relative risk for developing any malignancy after\n                      <jats:styled-content style=\"fixed-case\">BKP<\/jats:styled-content>\n                      yV infection was 1.13 (95% confidence interval [\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      ] 0.89\u20101.44). The adjusted relative risk for malignancy after\n                      <jats:styled-content style=\"fixed-case\">BKP<\/jats:styled-content>\n                      yV infection was greatest with\n                      <jats:styled-content style=\"fixed-case\">UCC<\/jats:styled-content>\n                      (8.21, 95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      0.75\u201089.7) and with metastatic disease of unknown etiology (8.21, 95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      0.75\u201089.7). The screening prevalence for\n                      <jats:styled-content style=\"fixed-case\">BKP<\/jats:styled-content>\n                      yV infection increased from 18% for those veterans who underwent transplantation in 2000 to 86% for those veterans who underwent transplantation in 2009, during which time the measured prevalence of\n                      <jats:styled-content style=\"fixed-case\">BKP<\/jats:styled-content>\n                      yV infection increased from 7% to 24%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      In this cohort of\n                      <jats:styled-content style=\"fixed-case\">KTR<\/jats:styled-content>\n                      veterans, no overall increased or decreased relative risk for malignancy was associated with evidence of prior\n                      <jats:styled-content style=\"fixed-case\">BKP<\/jats:styled-content>\n                      yV infection. A &gt;8\u2010fold increased risk of developing\n                      <jats:styled-content style=\"fixed-case\">UCC<\/jats:styled-content>\n                      after\n                      <jats:styled-content style=\"fixed-case\">BKP<\/jats:styled-content>\n                      yV infection was seen, although this risk was not found to be statistically significant.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/tid.12752","type":"journal-article","created":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T11:16:50Z","timestamp":1500549410000},"source":"Crossref","is-referenced-by-count":23,"title":["Urothelial cell carcinoma after BK polyomavirus infection in kidney transplant recipients: A cohort study of veterans"],"prefix":"10.1111","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0268-0188","authenticated-orcid":false,"given":"Ralph","family":"Rogers","sequence":"first","affiliation":[{"name":"Department of Medicine Providence VA Medical Center  Providence RI USA"},{"name":"Department of Medicine Alpert Medical School of Brown University  Providence RI USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reginald","family":"Gohh","sequence":"additional","affiliation":[{"name":"Department of Medicine Alpert Medical School of Brown University  Providence RI USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Noska","sequence":"additional","affiliation":[{"name":"Department of Medicine Providence VA Medical Center  Providence RI USA"},{"name":"Department of Medicine Alpert Medical School of Brown University  Providence RI USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,9,16]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001333"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2012.12.015"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12110"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/nep.12728"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(71)91776-4"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-011110-130227"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2015.10.003"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13550"},{"key":"e_1_2_6_10_1","volume-title":"IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 104: Malaria and Some Polyomaviruses (SV40, BK, JC, and Merkel Cell Viruses)","author":"International Agency for Research on Cancer","year":"2012"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2012.09.019"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.4584"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00771-16"},{"key":"e_1_2_6_14_1","first-page":"487","article-title":"Low frequency of human polyomavirus BKV and JCV DNA in urothelial carcinomas of the renal pelvis and renal cell carcinomas","volume":"10","author":"Knoll A","year":"2003","journal-title":"Oncol Rep"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22494"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.519"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.23559"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28053"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200206270-00015"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604711"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2008.08.138"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2010.02.068"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2013.01.008"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12072"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31828235ec"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12042"},{"key":"e_1_2_6_27_1","first-page":"26","article-title":"Polyomavirus BK in the pathogenesis of bladder cancer","volume":"71","author":"Van Aalderen MC","year":"2013","journal-title":"Neth J Med"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2013.09.037"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2015.04.008"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2015.04.009"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2015.09.021"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001260"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000000642"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21705"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020439"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001066"},{"key":"e_1_2_6_37_1","first-page":"57","article-title":"Urological tumors in renal transplantation","volume":"66","author":"Tillou X","year":"2014","journal-title":"Minerva Urol Nefrol"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2012.04209.x"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2004.00450.x"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02904.x"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-0016-5_16"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftid.12752","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tid.12752","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T07:33:29Z","timestamp":1695540809000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tid.12752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,16]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.1111\/tid.12752"],"URL":"https:\/\/doi.org\/10.1111\/tid.12752","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,16]]},"article-number":"e12752"}}